Literature DB >> 19197587

Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues.

Hyla H Polen1, Nile M Khanfar, Kevin A Clauson.   

Abstract

The pharmaceutical industry spends billions of dollars annually on direct-to-consumer advertising (DTCA). Patient perspectives on the impact of televised DTCA on health-related behaviors and issues were assessed by means of a 68-question survey. 58.6% of respondents believed that DTCA allowed consumers to have a more active role in managing their health. However, 27.6% felt DTCA caused confusion, and an alarming 17.8% of respondents stopped taking their medication because of concerns about serious side effects mentioned in DTCA. Overall, participants believed DTCA plays a useful role in health self-management; however, a considerable percentage thought that the cost outweighs the benefits.

Entities:  

Mesh:

Year:  2009        PMID: 19197587     DOI: 10.1080/07359680802473521

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  8 in total

1.  Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Authors:  Robert A Bell; Laramie D Taylor; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2010-02-21

Review 2.  Cancer-related direct-to-consumer advertising: a critical review.

Authors:  Emily Z Kontos; K Viswanath
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.

Authors:  Helen W Sullivan; Miriam Campbell
Journal:  J Health Commun       Date:  2015-06-29

4.  Learning from marketing: Rapid development of medication messages that engage patients.

Authors:  Veronica Yank; Erika Tribett; Lydia Green; Jasmine Pettis
Journal:  Patient Educ Couns       Date:  2015-03-14

5.  General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA.

Authors:  Mahmoud S Al-Haddad; Fayez Hamam; Sami M Al-Shakhshir
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

Review 6.  Overcoming obstacles in risk factor management in type 2 diabetes mellitus.

Authors:  Yehuda Handelsman; Paul S Jellinger
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-14       Impact factor: 3.738

7.  Consumers' experience with and attitudes toward direct-to-consumer prescription drug promotion: a nationally representative survey.

Authors:  Kathryn J Aikin; Helen W Sullivan; Jennifer Berktold; Karen L Stein; Victoria J Hoverman
Journal:  Health Mark Q       Date:  2021-07-09

8.  The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors.

Authors:  Maram AlShammari; Ghadah Assiri; Mohammed Bin Buraykan; Yasser Almogbel; Azher Arafah; Adel Bashatah; Yazed AlRuthia
Journal:  Patient Prefer Adherence       Date:  2020-03-20       Impact factor: 2.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.